FDA Again Advises Against Morcellators for Fibroids FDA Again Advises Against Morcellators for Fibroids

The risk for uterine sarcoma being found in fibroids is too high, notes Dr Markman.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Related Links:

Morcellation of undiagnosed uterine sarcoma is cause of abdominal/pelvic dissemination, residual tumor and recurrence. In the preoperative evaluation of suspect uterine masses, magnetic resonance imaging (MRI)...
Source: BMC Women's Health - Category: OBGYN Authors: Tags: Case report Source Type: research
Like other uterine sarcomas, low-grade endometrial stromal sarcomas (LG-ESS) are a very rare tumor entity. In the past, research studies therefore discussed the various different types of the disease in combination. In addition, the classification of endometrial stromal tumors presented difficulties for quite some time so that in earlier studies it was not always possible to precisely distinguish between LG-ESS, high-grade endometrial stromal sarcoma, and undifferentiated uterine sarcoma. For LG-ESS, surgery with hysterectomy and adnexectomy is the first-line treatment. The benefits of lymphadenectomy and tumor debulking a...
Source: Oncology Research and Treatment - Category: Cancer & Oncology Source Type: research
Oncol Res Treat
Source: Oncology Research and Treatment - Category: Cancer & Oncology Source Type: research
Uterine adenosarcoma is a rare malignancy. It is defined as a biphasic tumor composed of both sarcomatous stroma and benign epithelium. While the sarcomatous component usually is a low-grade homologous uterine sarcoma, the epithelium most often consists of endometrium-like cells. If the sarcomatous part occupies more than 25% of the tumor volume, the situation is referred to as sarcomatous overgrowth - accounting for about 10% of cases. While adenosarcoma usually may be considered a tumor of low malignant potential, the sarcomatous overgrowth most often presents as high-grade sarcoma and is associated with aggressive clini...
Source: Oncology Research and Treatment - Category: Cancer & Oncology Source Type: research
Ultrasound in Obstetrics&Gynecology,Volume 52, Issue S1, Page 18-18, October 2018.
Source: Ultrasound in Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
Ultrasound in Obstetrics&Gynecology,Volume 52, Issue S1, Page 86-86, October 2018.
Source: Ultrasound in Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
Ultrasound in Obstetrics&Gynecology,Volume 52, Issue S1, Page 87-87, October 2018.
Source: Ultrasound in Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
Ultrasound in Obstetrics&Gynecology,Volume 52, Issue S1, Page 268-269, October 2018.
Source: Ultrasound in Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
Ultrasound in Obstetrics&Gynecology,Volume 52, Issue S1, Page 18-18, October 2018.
Source: Ultrasound in Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
Ultrasound in Obstetrics&Gynecology,Volume 52, Issue S1, Page 86-86, October 2018.
Source: Ultrasound in Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
More News: Cancer & Oncology | Health | Hematology | Sarcomas | Uterine Sarcoma